JP2022548217A5 - - Google Patents
Info
- Publication number
- JP2022548217A5 JP2022548217A5 JP2022515060A JP2022515060A JP2022548217A5 JP 2022548217 A5 JP2022548217 A5 JP 2022548217A5 JP 2022515060 A JP2022515060 A JP 2022515060A JP 2022515060 A JP2022515060 A JP 2022515060A JP 2022548217 A5 JP2022548217 A5 JP 2022548217A5
- Authority
- JP
- Japan
- Prior art keywords
- organ
- pharmaceutical composition
- tissue
- viral vector
- inflammation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1912863.6A GB201912863D0 (en) | 2019-09-06 | 2019-09-06 | Novel method |
| GB1912863.6 | 2019-09-06 | ||
| PCT/GB2020/052148 WO2021044175A1 (en) | 2019-09-06 | 2020-09-07 | Novel method |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022548217A JP2022548217A (ja) | 2022-11-17 |
| JP2022548217A5 true JP2022548217A5 (cg-RX-API-DMAC7.html) | 2023-09-11 |
| JP7737979B2 JP7737979B2 (ja) | 2025-09-11 |
Family
ID=68241092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022515060A Active JP7737979B2 (ja) | 2019-09-06 | 2020-09-07 | 新規法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220220180A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4025226A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7737979B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230035210A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115397441A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020341114A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3153063A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB201912863D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021044175A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL307633A (en) * | 2021-04-12 | 2023-12-01 | Univ Pennsylvania | Useful preparations in the treatment of spinal muscular atrophy (SBMA) |
| GB202118073D0 (en) | 2021-12-14 | 2022-01-26 | Babraham Inst | Novel method and composition comprising IL-2 and a tissue- or organ-specific targeting moiety |
| GB202202628D0 (en) | 2022-02-25 | 2022-04-13 | Babraham Inst | Novel use and method comprising IL-2 and a tissue- or organic-specific targeting moiety |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017060510A1 (en) | 2015-10-09 | 2017-04-13 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of alzheimer's disease |
| KR102423442B1 (ko) * | 2015-12-11 | 2022-07-20 | 캘리포니아 인스티튜트 오브 테크놀로지 | 아데노-관련 바이러스를 지시하기 위한 타겟팅 펩타이드 |
-
2019
- 2019-09-06 GB GBGB1912863.6A patent/GB201912863D0/en not_active Ceased
-
2020
- 2020-09-07 AU AU2020341114A patent/AU2020341114A1/en active Pending
- 2020-09-07 CA CA3153063A patent/CA3153063A1/en active Pending
- 2020-09-07 WO PCT/GB2020/052148 patent/WO2021044175A1/en not_active Ceased
- 2020-09-07 JP JP2022515060A patent/JP7737979B2/ja active Active
- 2020-09-07 CN CN202080077678.3A patent/CN115397441A/zh active Pending
- 2020-09-07 EP EP20771603.6A patent/EP4025226A1/en active Pending
- 2020-09-07 KR KR1020227010908A patent/KR20230035210A/ko not_active Ceased
-
2022
- 2022-03-04 US US17/653,554 patent/US20220220180A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gao et al. | Autophagy activation represses pyroptosis through the IL-13 and JAK1/STAT1 pathways in a mouse model of moderate traumatic brain injury | |
| JP2022548217A5 (cg-RX-API-DMAC7.html) | ||
| Gaire | Microglia as the critical regulators of neuroprotection and functional recovery in cerebral ischemia | |
| Ghosh et al. | Axonal regeneration in zebrafish spinal cord | |
| Aronica et al. | Neuroinflammatory targets and treatments for epilepsy validated in experimental models | |
| Nayak et al. | Microglia development and function | |
| Siebert et al. | Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repair | |
| Citraro et al. | Effects of histone deacetylase inhibitors on the development of epilepsy and psychiatric comorbidity in WAG/Rij rats | |
| Chen et al. | Adeno-associated virus-mediated L1 expression promotes functional recovery after spinal cord injury | |
| Robel | Astroglial scarring and seizures: a cell biological perspective on epilepsy | |
| Liebert et al. | Neuroprotective effects against POCD by photobiomodulation: evidence from assembly/disassembly of the cytoskeleton | |
| Duan et al. | Protection and treatment of sensorineural hearing disorders caused by exogenous factors: experimental findings and potential clinical application | |
| Kim et al. | Advances in molecular therapies for targeting pathophysiology in spinal cord injury | |
| Gutiérrez et al. | Reboxetine treatment reduces neuroinflammation and neurodegeneration in the 5xFAD mouse model of Alzheimer’s disease: role of CCL2 | |
| Hassan et al. | Acute intermittent hypoxia and rehabilitative training following cervical spinal injury alters neuronal hypoxia-and plasticity-associated protein expression | |
| Stratton et al. | The immunomodulatory properties of adult skin‐derived precursor S chwann cells: implications for peripheral nerve injury therapy | |
| Liu et al. | Overexpression of zinc-α2-glycoprotein suppressed seizures and seizure-related neuroflammation in pentylenetetrazol-kindled rats | |
| Kvistad et al. | Neural regeneration in the human central nervous system—from understanding the underlying mechanisms to developing treatments. Where do we stand today? | |
| Rahimi et al. | Study of nerve cell regeneration on nanofibers containing cerium oxide nanoparticles in a spinal cord injury model in rats | |
| US20240065988A1 (en) | Combined use of ketamine and retigabine (ezogabine) for the treatment of psychiatric disorders | |
| ES2412481T3 (es) | Inhibidores de la fosfodiesterasa 4 para la rehabilitación motora | |
| Chen et al. | Chd8 rescued TBI-induced neurological deficits by suppressing apoptosis and autophagy via Wnt signaling pathway | |
| Li et al. | Krüppel-like factor 7 attenuates hippocampal neuronal injury after traumatic brain injury | |
| Wu et al. | Conditional knockout of IL-1R1 in endothelial cells attenuates seizures and neurodegeneration via inhibiting neuroinflammation mediated by Nrf2/HO-1/NLRP3 signaling in status epilepticus model | |
| Chen et al. | Co-transduction of dual-adeno-associated virus vectors in the neonatal and adult mouse utricles |